Although numerous studies have explored CRC and microbes and find the effect of Fn bacteria on CRC, not all short-term survival cancer patients have Fn enrichment, and the composition of the human CRC microbiome that contributes favorably or adversely to outcomes of CRC remains incompletely studied. This evidence concerns the gene FN1 and cancer.